IDBS Launches Updates for ActivityBase and ActivityBase XE

IDBS Launches Updates for ActivityBase and ActivityBase XE

By Pharma Tech Outlook | Wednesday, January 08, 2020

Paul Denny-Gouldson, VP, Strategic Solutions

The data analysis solutions are designed to enhance the capabilities of research institutions, pharmaceutical companies, and CROs.

FREMONT, CA: The digitalization in the pharmaceutical sector has spurred the generation of vast structured and unstructured data on research, development, and trials. The data is usually stored in silos across the organization, which leads to challenges in data management, integration, and security. To alleviate the problems faced by pharmaceutical companies, IDBS has developed robust cloud-based R&D data management solutions.

Headquartered in the UK, IDBS has over 28 years of experience in helping pharmaceutical and biotech organizations with its proprietary platforms, ActivityBase, and E-WorkBook Cloud. ActivityBase has a proven presence in the R&D sector and is widely leveraged for screening data management, with feature-rich data analysis tools, build-in object and compound registration tools, and industry-standard database.

ActivityBase empowers pharmaceutical companies, academic research institutions, and CROs to conduct high throughput screening (HTS), low throughput screening (LTS), and high contrast screening (HCS) analysis. The supporting solutions and integrations offered by the IDBS collaborators bolster the capabilities of ActivityBase. The offerings of IDBS have facilitated effective collaboration between pharma, biotech, and CROs, reducing product complexity and enhancing workflow through a modern web experience. Its solutions enable mobile data processing, with algorithms designed to correct data and bolster new calculations.

In an exclusive interview with Pharma Tech Outlook Magazine, Paul Denny-Gouldson, VP of Strategic Solutions, IDBS, said, “Our solutions help organizations integrate data and processes across every stage of the drug discovery and development procedure, be it identification or manufacturing, supporting all disciplines involved—chemistry, biology, and analytical—in both validated and non-validated environments.”

Recently, IDBS released the latest versions of its proprietary solutions, ActivityBase and ActivityBase XE version 9.5. The releases come as a part of the company’s regular bi-annual product release aimed to assist its pharmaceutical and biotech clients.

The updates are based on direct customer feedback, and bring new functionality to the platforms, addressing the critical customer defects. The company aims to increase its investment in the platform and continue working with its clients to establish ActivityBase as the best software offering for high throughput and low volume screening. The contributions of IDBS have earned it a place in Pharma Tech Outlook’s Top 10 Enterprise Software Solution Providers – 2018.”

Weekly Brief

Read Also